We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Neurology |

Highlights FREE

JAMA Neurol. 2016;73(2):141. doi:10.1001/jamaneurol.2015.2437.
Text Size: A A A
Published online


Itrat et al test whether telemedicine is reliable and remote physician presence is adequate for acute stroke treatment using mobile stroke treatment units (MSTUs). They compared the evaluation and treatment of patients on the MSTU with a control group of patients brought to the emergency department via ambulance during the same year. They found that an MSTU using telemedicine is feasible, with a low rate of technical failure, and may provide an avenue for reducing the high cost of such systems. Editorial perspective is provided by Martin Ebinger, MD, and Heinrich J. Audebert, MD.

Auriel and coauthors test the sensitivity and specificity of clinical and neuroimaging-based criteria for cerebral amyloid angiopathy–related inflammation (CAA-ri). They measured prespecified criteria for probable CAA-ri and possible CAA-ri. Their data suggest that a reliable diagnosis of CAA-ri can be reached from basic clinical and magnetic resonance imaging information alone, with good sensitivity and excellent specificity.

Lehallier and colleagues optimize prediction of progression from mild cognitive impairment (MCI) to Alzheimer disease (AD) dementia by combining information from diverse patient variables. They determine whether combinations of markers could predict progression from MCI to AD within 1 to 6 years. Their study findings suggest that a combination of markers measured in plasma and cerebrospinal fluid, distinct from β-amyloid and tau, could prove useful in predicting midterm progression from MCI to AD dementia.


Longbrake and Cross hypothesize that the unequivocal success of B-cell–depleting agents in reducing magnetic resonance imaging and clinical activity in therapeutic trials indicates that B cells play a vital role in mediating the clinical course of relapsing multiple sclerosis (MS). They examine the effects of MS disease-modifying therapies (DMTs) on B-cell immunity and report that most DMTs induced B-cell production of the anti-inflammatory cytokine interleukin 10 while inhibiting B-cell expression of proinflammatory cytokines.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.